Development of a Documentation Rubric and Assessment of Pharmacists’ Competency for Documentation in the Patient Health Record by Baranski, Brittany et al.
E61CJHP – Vol. 70, No. 6 – November–December 2017 JCPH – Vol. 70, no 6 – novembre–décembre 2017
Supplementary material for Baranski B, Bolt J, Albers L, Siddiqui R, Bell A, Semchuk W. Development of a documentation rubric and assessment of pharmacists’
competency for documentation in the patient health record. Can J Hosp Pharm. 2017;70(6):423-9.
This single copy is for your personal, non-commercial use only.
For permission to reprint multiple copies or to order presentation-ready copies for distribution, contact CJHP at publications@cshp.ca
Appendix 1 (part 1 of 3): Tool for assessing pharmacists’ competency for documentation in the patient health record
                                                                           Document Attributes
Element                        Element Descriptor
1a                              Date                                                      Yes                                              No
1b                             Time                                                      Yes                                              No
2a                              Identity of the pharmacist                     Yes                                              No
                                 recording the entry
2b                             Contact information of the                   Yes                                              No
                                 pharmacist recording 
                                 the entry
3                               Note is legible                                        Yes                                              No
4                               Appropriate use of 
                                 abbreviations, acronyms,                       Yes                                              No
                                 and jargon
                                                                                                   Know                                  Comprehend                                  Apply
5                               Note is concise                       States information relevant        Summarizes information            Produces information important
                                                                               to the purpose of the note        relevant to the purpose of the    to the purpose of the note, 
                                                                               but includes excessive                note, but includes a minimal      without including irrelevant
                                                                               non-relevant information,          amount of additional                 data.
                                                                               which is distracting.                    information that is not directly 
                                                                                                                                  relevant to the assessment 
                                                                                                                                  and plan of the specific DRP.
6                               Clarity (organization of          Outlines note in an                     Selects appropriate                     Produces a well-articulated note
                                 note, not content)                  unorganized manner.                 organization of data that           that contains relevant 
                                                                                                                                  enables subjective and               information to support clear
                                                                                                                                  objective information to             recommendations and time-
                                                                                                                                  support the assessment, and     lines that ensure accountability
                                                                                                                                  the recommendation(s).             for actions required (e.g. states 
                                                                                                                                                                                    who will monitor and follow 
                                                                                                                                                                                    up, and when).
7                               Written in a diplomatic tone,  Avoids the use of inappropriate  Uses appropriate terms such      Avoids being judgmental (e.g. 
                                 using appropriate language   terms such as: wrong,                as: may benefit from, may         avoids inappropriate terms
                                 for the audience                    unnecessary, must, should,        improve with, may no longer     listed in “Know” of this
                                                                               inappropriate/not appropriate,   require, suggest, recommend,   section, and instead uses
                                                                               patient does not want.               consider, patient would prefer,  appropriate terms listed in
                                                                                                                                  patient unlikely to adhere to,     “Comprehend”), and focuses
                                                                                                                                  patient stated.                            on solutions rather than 
                                                                                                                                                                                    problems.
8                               Reason for note (e.g. titled)    Defines a generic reason for      The title identifies the drug-       The title illustrates why the
                                                                               the note in the title (e.g.            related concern, or specific         drug-related concern or activity
                                                                               “drug related problem”,            pharmacist activity (e.g. “Drug   is important (e.g. “Potential
                                                                               “medication change”,               interaction with warfarin and     increased bleed risk due to 
                                                                               “patient education”).                 azithromycin”).                           drug interaction with warfarin 
                                                                                                                                                                                    and azithromycin”).
                                                                                                    Elements of Care
                                    Missing                      Know                                 Comprehend                                   Apply                               NA
9      Overall data/                        Lists subjective and objective       Summarizes subjective and         Produces subjective and
        information to                    information that is relevant to     objective information to support  objective information to
        support                               the assessment and plan.            the assessment and plan with    support the assessment and
        assessment                         Includes irrelevant information    either including irrelevant           plan without including
        and plan                              AND is missing important           information OR missing              irrelevant information, or
                                                   information.                                important information               missing important information.
                                                                                                      (i.e. not both).                            
10    Medication list          X        Lists current (and previous)         Describes medications                Produces list of medications       NA (e.g. patient
                                                   medications pertinent to the      pertinent to the note including  pertinent to the note and          non-drug
                                                   note, but lacks information        dose, dosage form, and             indicates information relevant    education)
                                                   about dose, dosage form and    frequency (e.g. lists all current    to assessment and plan
                                                   frequency. Includes medications  medications patient is on for      (e.g. loading doses provided,
                                                   not relevant to the DRP.              HF if the note is regarding a       dose titrations, when 
                                                                                                      HF DRP/activity).                          medication started, and actual 
                                                                                                                                                         usage of prns). 
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                                                                                                    Elements of Care
                                    Missing                      Know                                 Comprehend                                   Apply                               NA
11    Reason that the        X        States that drug treatment          Explains why drug treatment      Produces a list of active and       NA
        drug treatment                   was stopped.                              was stopped and when              recently discontinued 
        was stopped                                                                          (provides date).                           mediations with rationale.
        (if relevant 
        i.e. in the 
        medication list, 
        not one of the 
        recommend-
        ations)
12    Patient’s                    X        States whether patient or           Describes patient’s medication    Produces relevant information    NA (e.g. there
        subjective                           caregiver was consulted.             experience, and includes            regarding patient’s experience    are no adverse
        experience with                                                                      additional information that is     with medication. No                   events relevant
        medication,                                                                           not directly relevant to the          unnecessary information is         to the DRP)
        with regards to                                                                      specific DRP.                                included.                                    
        a potential or                                                                                                                            
        actual DRP 
13    Drug therapy            X        States drug therapy problems     Produces clear drug therapy       Identifies current drug therapy   NA
        problems                            (or potential problems),              problem statements including:   problem(s) and describes their
        identified                             including drugs that are             drug, how it is involved OR        impact on the patient /disease
                                                   involved.                                     what is the impact on the          state (e.g. “Patient is receiving
                                                                                                      patient (e.g. “Patient receiving   azithromycin and warfarin
                                                                                                      azithromycin and warfarin         which interact and increase
                                                                                                      which interact” OR “Patient is   the risk of bleeding”).
                                                                                                      at increased risk of bleeding”).   
14    Rationale for            X        States conclusions, action           Describes the rationale for         Produces rationale that               NA (e.g. patient
        conclusions                         plans, or recommendations         conclusions, action plans, or       supports drug                             educated)
        drawn, action                     (e.g. “Patient would benefit        recommendations made (e.g.     recommendations. Identifies       
        plans, or                             from an increased dose of           “Patient’s blood pressure is not  therapeutic goals/targets/           
        recommend-                       beta-blocker).                              well controlled on current dose  desired outcomes. (“BP=150/95,
        ations made                                                                           of beta-blocker and would         target is BP less than 140/90.     
                                                                                                      benefit from an increased          Patient’s blood pressure is not
                                                                                                      dose”).                                       well controlled on current dose
                                                                                                                                                         of beta-blocker and would 
                                                                                                                                                         benefit from increasing 
                                                                                                                                                         metoprolol to 25mg BID today.) 
15    Decision(s) or            X        Lists drug and non-drug              Describes recommendations       Produces drug and non-drug      NA (e.g. patient
        recommend-                       recommendations in very           for drug therapy that are            recommendations, which           teaching)
        ations for                            general statements. Orders         complete; recommendations     include: drug, dose, dosage       
        changing drug                    may be unclear or lack               include drug, dose, dosage        form, route, and duration
        therapy                               decisiveness (e.g.                        form, route, and duration           (if appropriate). Includes timing
        (adding,                              “Re-evaluation of blood              (if appropriate).                           of when to start new                 
        stopping or                         pressure medications required”,                                                     medications, as well as stop
        changing)                            “Stop opioid analgesics”,                                                              and change existing 
                                                   “Re-evaluate need for                                                                   medications.
                                                   zopiclone”).                                                                                                                                     
16    Decision(s) or            X        Lists recommendations for          Describes the desired range of    Identifies desired ranges of         NA
        recommend-                       monitoring drug therapy             clinical and lab values (e.g.         clinical and lab values, their 
        ation(s) for                          including identification of           change in SCr >30%).                frequency and who will 
        monitoring                         suitable clinical or laboratory                                                         follow-up on these values and
        drug therapy                      tests.                                                                                              what to do at given values 
        and follow-up                                                                                                                          (e.g. Physician to monitor SCr 
                                                                                                                                                         every 5 days and hold ACEi if 
                                                                                                                                                         change in SCr >30% from 
                                                                                                                                                         baseline).
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                                                                                                    Elements of Care
                                    Missing                      Know                                 Comprehend                                   Apply                               NA
17    Description of           X        Lists activities performed by        Describes the activities               Identifies assessment of             NA
        activities                              pharmacist in very general          performed by pharmacist in       patient understanding, i.e. 
        performed by                     terms (e.g. “Educated patient     detail, providing more                any concerns arising from
        pharmacist                          on heart failure medications”).   information than required (e.g.  activities that require further
        (e.g. patient                                                                           “Educated patient about HF       action, and how activities may
        education,                                                                             medications including how         impact future drug therapy
        applying for                                                                           to take them, benefits                (e.g. “Patient is capable of
        special access,                                                                        including preventing                   monitoring daily weights and
        applying for                                                                           hospitalization and progression  showed a good understanding
        EDS, continuity                                                                       of HF, side effects including        of how to adjust Lasix
        of care activities)                                                                     fatigue, decreased exercise        accordingly”, “Patient 
                                                                                                      capacity that will improve with  appeared to lack understanding
                                                                                                      time, and when to seek medical  of medication administration”).
                                                                                                      attention including gaining 
                                                                                                      weight >2lbs in 2 days or 
                                                                                                      5lbs in one week”).                    
18    Lists                          X        Communications with other       Describes the consult and           Identifies specific practitioner     NA
        communication                   healthcare professionals are        includes either the specific         consulted, and what was
        with other                          listed, if appropriate (e.g.            practitioner consulted OR what  discussed regarding drug
        healthcare                          “discussed above with                was discussed regarding drug    therapy (e.g. “Discussed with
        professionals                       attending physician”).                 therapy (e.g. “Discussed with    Dr. X the current barriers to
                                                                                                      Dr X” OR “Discussed concerns  patient receiving regular blood
                                                                                                      about drug interaction with       work and thus why warfarin
                                                                                                      attending physician”).                is not a viable option”). 
ACEi = angiotensin-converting enzyme inhibitor, BP = blood pressure, DRP = drug-related problem, EDS = Exception Drug Status, HF = heart failure,
NA = not applicable, SCr = serum creatinine
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